Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Drug companies are racing to produce GLP-1s in the form of a daily pill instead of requiring weekly injections, among other potential advances
Corporate food manufacturers are adopting portfolio relabeling strategies that require minimal R&D investment but offer limited defensibility
Additionally,certain medications that many patients take before and after surgery can decrease vitamin B 12 absorption and stores in the body
*Correspondence: Shokrollah Elahi, [email protected] ORCID: Shokrollah Elahi, orcid.org/0000-0002-7215-2009 Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
PMID: 26095006 Clinical trial data on file: AOD9604 12-week double-blind placebo-controlled study in overweight adults
)
